PT2097064E - Terapia anaplerótica de doença de huntington e de outras doenças de poliglutamina - Google Patents
Terapia anaplerótica de doença de huntington e de outras doenças de poliglutamina Download PDFInfo
- Publication number
- PT2097064E PT2097064E PT78476926T PT07847692T PT2097064E PT 2097064 E PT2097064 E PT 2097064E PT 78476926 T PT78476926 T PT 78476926T PT 07847692 T PT07847692 T PT 07847692T PT 2097064 E PT2097064 E PT 2097064E
- Authority
- PT
- Portugal
- Prior art keywords
- huntington disease
- polyglutamine diseases
- anaplerotic therapy
- anaplerotic
- therapy
- Prior art date
Links
- 208000023105 Huntington disease Diseases 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 229920000155 polyglutamine Polymers 0.000 title 1
- 108010040003 polyglutamine Proteins 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/225—Polycarboxylic acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/03—Organic compounds
- A23L29/035—Organic compounds containing oxygen as heteroatom
- A23L29/04—Fatty acids or derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06291873A EP1929995A1 (en) | 2006-12-04 | 2006-12-04 | Anaplerotic therapy of Huntington disease and other polyglutamine diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT2097064E true PT2097064E (pt) | 2015-11-25 |
Family
ID=37733780
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT78476926T PT2097064E (pt) | 2006-12-04 | 2007-12-03 | Terapia anaplerótica de doença de huntington e de outras doenças de poliglutamina |
Country Status (11)
| Country | Link |
|---|---|
| US (5) | US20100063147A1 (pt) |
| EP (3) | EP1929995A1 (pt) |
| CY (1) | CY1116938T1 (pt) |
| DK (1) | DK2097064T3 (pt) |
| ES (2) | ES2778525T3 (pt) |
| HK (1) | HK1223829A1 (pt) |
| HU (1) | HUE026217T2 (pt) |
| PL (1) | PL2097064T3 (pt) |
| PT (1) | PT2097064E (pt) |
| SI (1) | SI2097064T1 (pt) |
| WO (1) | WO2008068230A1 (pt) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1929995A1 (en) | 2006-12-04 | 2008-06-11 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Anaplerotic therapy of Huntington disease and other polyglutamine diseases |
| JP5765839B2 (ja) * | 2009-12-05 | 2015-08-19 | 国立大学法人名古屋大学 | 球脊髄性筋萎縮症治療薬 |
| AU2010336921A1 (en) * | 2009-12-30 | 2012-07-26 | Baylor Research Institute | Anaplerotic therapy for Alzheimer's disease and the aging brain |
| JP2013528648A (ja) * | 2010-06-14 | 2013-07-11 | ベイラー リサーチ インスティテュート | 成人ポリグルコサン小体病（ａｐｂｄ）を処置するためのトリヘプタノイン食 |
| US9468229B2 (en) | 2012-12-13 | 2016-10-18 | National Institute Of Health And Medical Research | Triheptanoin for the treatment of glucose transport 1 deficiency |
| EP3068492B1 (en) * | 2013-11-14 | 2020-01-08 | The University of Queensland | Neurodegenerative disorders and methods of treatment and diagnosis thereof |
| US20170161441A1 (en) * | 2014-07-02 | 2017-06-08 | Ridge Diagnostics, Inc. | Methods and materials for treating pain and depression |
| CA3026152A1 (en) | 2016-06-08 | 2017-12-14 | Sunregen Healthcare Ag | Lipids with odd number of carbon atoms and their use as pharmaceutical composition or nutritional supplement |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4025649A (en) | 1974-08-19 | 1977-05-24 | Labaz | Acetic acid derivatives having pharmacological activity and compositions containing the same |
| DE3032300A1 (de) | 1980-08-27 | 1982-04-01 | Alfred Ing. Wien Lohninger | Mittel zur parenteralen ernaehrung |
| GB2104079B (en) | 1981-08-14 | 1985-08-21 | London Polytech | New aminoacid isomers, their production and their medicinal use |
| US4753963A (en) | 1985-09-26 | 1988-06-28 | The Procter & Gamble Company | Nutritional fat suitable for enteral and parenteral products |
| JP3486778B2 (ja) | 1993-04-02 | 2004-01-13 | 三菱ウェルファーマ株式会社 | アルツハイマー病予防治療剤 |
| US20090253781A1 (en) | 2002-05-24 | 2009-10-08 | Btg International Limited | Therapeutic compositions |
| US6740679B1 (en) * | 1999-02-05 | 2004-05-25 | Baylor University Medical Center | Nutritional supplement or pharmaceutical preparation comprising triglycerides with seven-carbon fatty acid |
| CA2361070C (en) * | 1999-02-05 | 2012-04-17 | Baylor University Medical Center | Nutritional supplement or pharmaceutical preparation comprising triglycerides with seven-carbon fatty acid |
| WO2001032168A1 (en) | 1999-11-03 | 2001-05-10 | Juvenon, Inc. | Method of treating benign forgetfulness |
| US6835750B1 (en) * | 2000-05-01 | 2004-12-28 | Accera, Inc. | Use of medium chain triglycerides for the treatment and prevention of alzheimer's disease and other diseases resulting from reduced neuronal metabolism II |
| EP1292294B1 (en) | 2000-05-01 | 2009-03-18 | Accera, Inc. | Use of medium chain triglycerides for the treatment and prevention of alzheimer's disease |
| CN1756554A (zh) * | 2003-03-06 | 2006-04-05 | 艾克塞拉公司 | 新的化学实体和它们用于治疗代谢障碍的方法 |
| US8399515B2 (en) | 2003-05-20 | 2013-03-19 | Baylor Research Institute | Five and fifteen carbon fatty acids for treating metabolic disorders and as nutritional supplements |
| US8106093B2 (en) | 2004-07-02 | 2012-01-31 | Baylor Research Institute | Glycogen or polysaccharide storage disease treatment method |
| US7884115B2 (en) | 2004-09-28 | 2011-02-08 | Allergan, Inc. | Methods and compositions for the treatment of pain and other neurological conditions |
| EP2001293B9 (en) | 2006-04-03 | 2019-04-17 | Accera, Inc. | Use of ketogenic compounds for treatment of age-associated memory impairment |
| AU2007300127A1 (en) | 2006-09-26 | 2008-04-03 | Baylor Research Institute | Nutrient sensor |
| EP1929995A1 (en) | 2006-12-04 | 2008-06-11 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Anaplerotic therapy of Huntington disease and other polyglutamine diseases |
| ES2556537T3 (es) | 2007-07-31 | 2016-01-18 | Accera, Inc. | Uso de ensayo genómico y compuestos cetogénicos para tratamiento de una función cognitiva reducida |
| WO2009124250A1 (en) | 2008-04-03 | 2009-10-08 | The Trustees Of The University Of Pennsylvania | Compositions and methods for detecting tricarboxylic acid (tca) metabolic flux |
| AU2010336921A1 (en) | 2009-12-30 | 2012-07-26 | Baylor Research Institute | Anaplerotic therapy for Alzheimer's disease and the aging brain |
| US20110301238A1 (en) | 2010-06-02 | 2011-12-08 | Borges Karin | Seizure related disorders and therapeutic methods thereof |
| JP2013528648A (ja) | 2010-06-14 | 2013-07-11 | ベイラー リサーチ インスティテュート | 成人ポリグルコサン小体病（ａｐｂｄ）を処置するためのトリヘプタノイン食 |
| SG191297A1 (en) | 2010-12-23 | 2013-07-31 | Amazentis Sa | Compositions and methods for improving mitochondrial function and treating neurodenegenerative diseases and cognitive disorders |
| US9468229B2 (en) | 2012-12-13 | 2016-10-18 | National Institute Of Health And Medical Research | Triheptanoin for the treatment of glucose transport 1 deficiency |
| EP3068492B1 (en) | 2013-11-14 | 2020-01-08 | The University of Queensland | Neurodegenerative disorders and methods of treatment and diagnosis thereof |
-
2006
- 2006-12-04 EP EP06291873A patent/EP1929995A1/en not_active Withdrawn
-
2007
- 2007-12-03 SI SI200731703T patent/SI2097064T1/sl unknown
- 2007-12-03 WO PCT/EP2007/063181 patent/WO2008068230A1/en active Application Filing
- 2007-12-03 ES ES15175719T patent/ES2778525T3/es active Active
- 2007-12-03 HU HUE07847692A patent/HUE026217T2/en unknown
- 2007-12-03 DK DK07847692.6T patent/DK2097064T3/en active
- 2007-12-03 US US12/516,486 patent/US20100063147A1/en not_active Abandoned
- 2007-12-03 PL PL07847692T patent/PL2097064T3/pl unknown
- 2007-12-03 EP EP15175719.2A patent/EP3009135B1/en active Active
- 2007-12-03 EP EP07847692.6A patent/EP2097064B1/en active Active
- 2007-12-03 ES ES07847692.6T patent/ES2552843T3/es active Active
- 2007-12-03 PT PT78476926T patent/PT2097064E/pt unknown
-
2011
- 2011-12-30 US US13/341,028 patent/US20120165405A1/en not_active Abandoned
-
2014
- 2014-06-19 US US14/308,966 patent/US9717705B2/en active Active
-
2015
- 2015-11-13 CY CY20151101025T patent/CY1116938T1/el unknown
-
2016
- 2016-10-20 HK HK16112074.6A patent/HK1223829A1/zh unknown
-
2017
- 2017-06-30 US US15/640,018 patent/US10220014B2/en active Active
-
2019
- 2019-02-04 US US16/267,210 patent/US20190365695A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20140364498A1 (en) | 2014-12-11 |
| US20190365695A1 (en) | 2019-12-05 |
| US20100063147A1 (en) | 2010-03-11 |
| HK1223829A1 (zh) | 2017-08-11 |
| DK2097064T3 (en) | 2015-11-23 |
| US20180021287A1 (en) | 2018-01-25 |
| SI2097064T1 (sl) | 2016-01-29 |
| EP1929995A1 (en) | 2008-06-11 |
| US9717705B2 (en) | 2017-08-01 |
| EP2097064A1 (en) | 2009-09-09 |
| EP2097064B1 (en) | 2015-08-19 |
| ES2552843T3 (es) | 2015-12-02 |
| US20120165405A1 (en) | 2012-06-28 |
| HUE026217T2 (en) | 2016-05-30 |
| CY1116938T1 (el) | 2017-04-05 |
| EP3009135A1 (en) | 2016-04-20 |
| US10220014B2 (en) | 2019-03-05 |
| EP3009135B1 (en) | 2020-02-05 |
| WO2008068230A1 (en) | 2008-06-12 |
| ES2778525T3 (es) | 2020-08-10 |
| PL2097064T3 (pl) | 2016-02-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2182983A4 (en) | TREATMENT OF AMYLOIDOGENIC DISEASES | |
| SI2097064T1 (sl) | Anaplerotična terapija huntingtonove bolezni in drugih poliglutaminskih bolezni | |
| EP1968607A4 (en) | TREATMENT OF CANCER AND OTHER DISEASES | |
| PL2056863T3 (pl) | Leczenie chorób oczu | |
| BRPI0720046A2 (pt) | Composição de suplemento nutricional para tratamento de doenças oculares | |
| HK1131047A1 (en) | Treatment of inflammatory diseases | |
| HK1201046A1 (en) | Methods of treating ophthalmic diseases | |
| PL2056842T3 (pl) | Modyfikowany galaktozyloceramid do leczenia chorób nowotworowych | |
| EP1962839A4 (en) | ADMINISTRATION OF A MNTOR INHIBITOR FOR THE TREATMENT OF PATIENTS WITH CANCER | |
| EP2004204A4 (en) | TREATMENT OF NEURODEGENERATIVE DISEASES | |
| EP2160100B8 (en) | Treatment of graft-versus-host disease | |
| HK1148684A1 (en) | Treatment of prion protein related diseases | |
| ZA200806808B (en) | Treatment of stressed patients | |
| EP1962869A4 (en) | TREATMENT OF RESPIRATORY DISEASES | |
| EP2026822A4 (en) | TOPICAL TREATMENT FOR EYE SURGERY DISEASES | |
| GB0610183D0 (en) | Treatment of neurodegenerative diseases | |
| EP2001488A4 (en) | PREVENTION AND TREATMENT OF CANCER AND OTHER DISEASES | |
| PL2056858T3 (pl) | Leczenie stanów chorobowych płuc | |
| EP2049899A4 (en) | METHOD FOR THE PREVENTION AND TREATMENT OF DISEASES | |
| GB0914423D0 (en) | Treatment of protein aggregation diseases | |
| BRPI0821539A2 (pt) | composição para a prevenção e o tratamento de doenças metabólicas compreendendo o extrato de lysimachiae foenum-graeci herma | |
| EP2025342A4 (en) | THERAPEUTIC AGENT OR DEVELOPMENT INHIBITOR OF POLYGLUTAMINE DISEASE | |
| EP2059238A4 (en) | THERAPEUTIC COMPOUNDS FOR DISEASES AND DISORDERS | |
| GB0623740D0 (en) | Treatment of disease | |
| GB0622136D0 (en) | Treatment of gastrointestinal diseases |